COVID-19 Vaccines and Therapeutics

Resources and information will be added and updated often as new developments occur.

When the novel coronavirus (SARS-CoV-2) emerged in late 2019, hundreds of individuals and organizations around the world quickly mobilized to develop a vaccine for COVID-19, the disease caused by the virus. As the virus surged in 2020, therapeutics were developed to treat those with COVID-19 in outpatient and inpatient settings.

This webpage is intended to help keep the field informed of important updates related to the progress and distribution of COVID-19 vaccines, along with in-development therapeutics for patients with COVID-19. 


AHA Members-Only Resources

  • COVID-19 Vaccination Resource

    This is a set of resources to help hospitals and health systems reassure staff, patients and communities of COVID-19 vaccines’ safety and effectiveness. It includes messaging for many important audiences, whether organizational (stakeholders inside hospitals or health systems) or public-facing (patients and communities). The resource also contains a distribution preparation and discussion guide, plus a COVID-19 labor readiness checklist.

  • COVID-19 Vaccine Candidate Scorecard

    This scorecard highlights the most promising COVID-19 vaccine candidates and has been updated regularly. Updated 11/16/2020

  • COVID-19 Treatments and Therapeutics Snapshot

    This snapshot provides an overview of three treatments including Veklury (remdesivir), Eli Lilly’s bamlanivimab, and Regeneron’s antibody cocktail.

  • COVID-19 Vaccine Primer

    This primer provides an overview of the U.S. vaccine development and approval process, as well as information on Operation Warp Speed.


Monoclonal Antibody Therapeutics

HHS COVID-19 Vaccine Communications and Distribution

COVID-19 Vaccine Allocation Frameworks

Understanding More about Vaccines

Related Resources

Leadership Rounds
Please join AHA Board Chair Melinda Estes, M.D., for the tenth in a series of Leadership Rounds. Dr. Estes is joined by Claire Zangerle, MSN, MBA, RN, Chief…
Testimony
Public
John Riggi, AHA senior advisor for cybersecurity and risk, testimony before the Senate Homeland Security and Governmental Affairs Committee on defending…
Leadership Rounds
Please join AHA Board Chair Melinda Estes, M.D., for the ninth in a series of Leadership Rounds — short conversations on a range of key issues Dr. Estes will…
Letter/Comment
Public
The AHA asks the Department of Health and Human Services (HHS) to take additional steps to increase flexibilities for providers responding to the COVID-19…
Advancing Health Podcast
Public
In this podcast, AJ Rolle, Senior Program Manager at the AHA, moderates a discussion between Marc Berejka, Director of Government & Community Affairs at…
Special Bulletin
Public
In an open letter to the American public, the AHA, along with the American Medical Association and American Nurses Association, today affirmed their support…